| Chinedu D Ede, MD | |
|
4310 W Markham St, Little Rock, AR 72205-4024 | |
| (501) 686-6560 | |
| Not Available |
| Full Name | Chinedu D Ede |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 4310 W Markham St, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043553167 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | E-9414 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Regional Medical Center | Pine bluff, AR | Hospital |
| Medical Center Of South Arkansas | El dorado, AR | Hospital |
| Drew Memorial Hospital | Monticello, AR | Hospital |
| Ashley County Medical Center | Crossett, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hcc Of El Dorado Llc | 1850789488 | 19 |
| Southeast Arkansas Hospitalists Llp | 9537479605 | 12 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Mercy Hospital Paris |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912955709 PECOS PAC ID: 0244135705 Enrollment ID: O20031206000120 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20120308000726 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Howard Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467852210 PECOS PAC ID: 7315851599 Enrollment ID: O20150616002502 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Southeast Arkansas Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912374018 PECOS PAC ID: 9537479605 Enrollment ID: O20151103000750 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Ess Of El Dorado, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861851131 PECOS PAC ID: 8325345432 Enrollment ID: O20160404001667 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Nes Kentucky Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902348048 PECOS PAC ID: 7416846076 Enrollment ID: O20161220000031 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Hmh Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972043073 PECOS PAC ID: 6608145529 Enrollment ID: O20170710001522 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Entity Name | Hcc Of El Dorado Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003578725 PECOS PAC ID: 1850789488 Enrollment ID: O20211101000418 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chinedu D Ede, MD 4310 W Markham St, Little Rock, AR 72205-4024 Ph: (501) 686-6560 | Chinedu D Ede, MD 4310 W Markham St, Little Rock, AR 72205-4024 Ph: (501) 686-6560 |
News Archive
Researchers at Lund University, Sweden, have taken a snapshot of proteins changing shape, sticking together and creating structures that are believed to trigger deadly processes in the nervous system. The discovery opens the possibility of designing drugs for a devastating neurological disease, ALS.
Before the COVID-19 pandemic took hold in the United States, Chris Trondsen felt his life was finally under control. As someone who has battled obsessive-compulsive disorder and other mental health issues since early childhood, it's been a long journey.
Malaria is still a deadly disease in tropical and subtropical regions. Every year the disease infects more than 200 million people worldwide, claiming several hundred thousand victims.
A study of welfare recipients in Indiana demonstrates that clients who seek social services from faith-based organizations (FBOs) are more likely to have experienced homelessness, not having enough to eat and other forms of extreme poverty in comparison to those who seek help only from nonreligious organizations (NROs).
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.
› Verified 8 days ago
Dr. William Lyman Rutledge, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 9712 W Markham St, Little Rock, AR 72205 Phone: 501-954-8800 Fax: 501-954-8803 | |
Allan Dee Mckenzie, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4523 Woodlawn Dr, Little Rock, AR 72205 Phone: 501-663-2363 Fax: 501-663-2362 | |
Dr. Steven Kyser, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-5050 | |
Kasey Renea Kane, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2200 S Bowman Rd, Little Rock, AR 72211 Phone: 501-558-4100 | |
Dr. William Wells Burnham, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-1000 Fax: 501-257-5071 | |
Deipti H Trehun, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4301 W Markham St # 530, Little Rock, AR 72205 Phone: 501-686-8000 Fax: 501-686-8421 | |
Dr. Pham Hieu Liem, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St, 748, Little Rock, AR 72205 Phone: 501-686-5944 Fax: 501-686-5884 |